Rudd P M, Fortune F, Patel T, Parekh R B, Dwek R A, Lehner T
Department of Biochemistry, University of Oxford, UK.
Immunology. 1994 Sep;83(1):99-106.
A receptor which binds secretory IgA (sIgA) is expressed on human T cells from patients with systemic lupus erythematosus, rheumatoid arthritis, Behcet's syndrome and IgA nephropathy and on normal T cells following phytohaemagglutinin (PHA) stimulation. The specificity of this receptor was initially probed with a panel of normal serum immunoglobulins in competitive inhibition assays with sIgA using two-colour immunofluorescence. While the receptor showed the strongest affinity for IgA1 (IC(50)10(-6) M), IgD which has a similarly glycosylated hinge region to IgA1, also bound to the receptor (IC50 10(-5) M). IgA2, which lacks the 'O'-glycosylated hinge region, did not significantly inhibit the binding at these concentrations suggesting that the IgA determinants for this receptor might be the oligosaccharides present in the hinge region of IgA1. IgA1 has up to 10 'O'-linked oligosaccharides and four N-linked oligosaccharides per molecule. In order to probe the role of the 'O'-linked hinge sugars in the binding event, a sugar library was prepared from IgA1 by a procedure designed to release 'O'-linked oligosaccharides preferentially, and to retain them in the natural closed ring formation. The sugars were released by hydrazinolysis at 65 degrees and the resulting oligosaccharide library analysed by high voltage paper electrophoresis (HVE) and P4 gel permeation chromatography. Competitive inhibition studies demonstrated that both the library and the individual 'O'-linked sugars associated with IgA1 were implicated in the binding of IgA1 to this receptor (IC50 between 1 x 10(-5) M and 6 x 10(-5) M). Within this range the individual sugars showed small differences in their affinity for the receptor in the following order: Gal beta 3GalNAc = NeuNAc2 alpha 3(6)Gal beta 3GalNAc > NeuNAc2 alpha 3(6)Gal beta 3[NeuNAc2 alpha 6]GalNAc > or = GalNAc.
系统性红斑狼疮、类风湿性关节炎、白塞氏综合征及IgA肾病患者的人T细胞以及经植物血凝素(PHA)刺激后的正常T细胞上均表达一种可结合分泌型IgA(sIgA)的受体。最初,在双色免疫荧光法中,采用一组正常血清免疫球蛋白与sIgA进行竞争性抑制试验,以此探究该受体的特异性。虽然该受体对IgA1表现出最强的亲和力(半数抑制浓度(IC50)为10⁻⁶ M),但与IgA1具有相似糖基化铰链区的IgD也能与该受体结合(IC50为10⁻⁵ M)。缺乏“O” - 糖基化铰链区的IgA2在这些浓度下并未显著抑制结合,这表明该受体识别IgA的决定簇可能是IgA1铰链区中的寡糖。每个IgA1分子含有多达10个“O” - 连接寡糖和4个N - 连接寡糖。为了探究“O” - 连接铰链糖在结合过程中的作用,通过一种旨在优先释放“O” - 连接寡糖并使其保持天然闭环形式的方法,从IgA1制备了一个糖库。通过在65℃下肼解释放糖类,并通过高压纸电泳(HVE)和P4凝胶渗透色谱法分析所得的寡糖库。竞争性抑制研究表明,该糖库以及与IgA1相关的单个“O” - 连接糖均参与了IgA1与该受体的结合(IC50在1×10⁻⁵ M至6×10⁻⁵ M之间)。在此范围内,单个糖类对受体的亲和力存在细微差异,顺序如下:Galβ3GalNAc = NeuNAc2α3(6)Galβ3GalNAc > NeuNAcα2α3(6)Galβ3[NeuNAc2α6]GalNAc ≥ GalNAc。